hails Spanish study results31 Jan 2023 19:06
Ondine Biomedical Inc - Canadian life sciences company focused in the field of photodisinfection therapies - Steriwave, Ondine's nasal photodisinfection therapy, has been found to improve short- and long-term immune responses while also "significantly" reducing SARS-CoV-2 infectivity. This effect was detectable not only in antibody-mediated immunity, but also in T-cell mediated immunity.
Chief Executive Officer Carolyn Cross says: "The Clinica Universidad de Navarra study sheds new light on the photodisinfection treatment of respiratory viruses, where antibiotics are entirely ineffective and new anti-viral therapies are limited. As new SARS-CoV-2 variants rapidly emerge across the globe, we look forward to being able to play our part in helping our communities, hospitals, clinics, and emergency workers deal with these new threats."